Filing Flows › Abbott Laboratories (ABT) › Q1 2026
Abbott Laboratories (ABT) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 29, 2026
Abbott Laboratories (ABT) reported revenue of $11.2B for the first quarter 2026 (Q1 2026), +8% from a year earlier and -3% from the quarter before. Operating margin was 12.0%, net earnings $1.1B (9.6% of revenue).
Abbott Laboratories, Q1 2026: revenue $11.2B (+8% year over year), operating margin 12.0%, net earnings $1.1B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.2B | -3% | +8% |
| Operating profit | $1.3B | -40% | -21% |
| Net earnings | $1.1B | -39% | -19% |
| Operating cash flow | $1.3B | -60% | -7% |
| Free cash flow | $916M | -65% | -2% |
What changed
Revenue was $11.2B in Q1 2026, up 8% year over year and down 3% from the previous quarter.
Operating profit was $1.3B, a 12.0% margin (down 4.3 points year over year). Operating profit fell $0.35B even though revenue rose $0.81B versus Q1 2025, so costs grew faster than sales. Total costs grew 13% against revenue growth of 8%. The fastest-growing cost line was SG&A (+22%). Net earnings were $1.1B, down 19% year over year. The effective tax rate was 25.7%.
Operating cash flow was $1.3B (down 7% year over year), 122% of net earnings. Non-cash charges added back $0.80B of depreciation and amortization and $0.32B of share-based compensation. Working capital and other items used $0.88B. Capital expenditures of $0.40B left free cash flow of $0.92B.
Questions
What was Abbott Laboratories' revenue in the first quarter 2026?
Abbott Laboratories (ABT) reported revenue of $11.2B for the first quarter 2026 (Q1 2026), +8% from a year earlier and -3% from the quarter before.
Was Abbott Laboratories profitable in the first quarter 2026?
Operating profit was $1.3B (12.0% of revenue) and net earnings $1.1B.